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The Cardiac Ryanodine Receptor (RyR2): Investigating Mechanisms of
Gating at the Selectivity Filter
Jahn M. Firth, Joanne Euden, Alan J. Williams.
Institute of Molecular and Experimental Medicine, Cardiff, United Kingdom.
Ryanodine receptors (RyR) provide the pathway for release of intracellular
calcium ions (Ca2þ) that initiate muscle contraction. Mutations in cardiac
RyRs, (RyR2) underlie arrhythmia and sudden cardiac death. RyRs are therefore
an attractive therapeutic target, howevermore information regarding structure and
function is required.The enormoussizeofRyRsprecludes detailed structural anal-
ysis. Models, based on potassium channel templates, exist for the RyR pore-
forming region (PFR) providing an invaluable framework in which predictions
of specific processes of ion translocation and gating mechanisms can be tested.
Potassium channels have a conserved gating mechanism involving a distinct
hydrogen-bonding network of residues at the selectivity filter that is responsible
for holding the filter in an inactive, non-conducting conformation. This study
examines interactions of equivalent residues in RyR2 to ascertain whether a
similar gating mechanism exists.
Three alanine (D4829A, Y4813A, Y4839A) and one conserved tryptophan
(Y4839W) RyR2 mutations were constructed to assess a proposed hydrogen-
bonding network. Mutated channels formed functional homotetramers in
vivo whereby they released Ca2þ upon caffeine addition. Differences in
[3H]-ryanodine binding on isolatedWT and mutant mix membrane populations
revealed 1) altered ryanodine binding site and/or 2) altered calcium sensitivity
for mutant channels. Preliminary single-channel experiments assessing ion
handling and gating properties under steady state conditions suggest that the
selectivity filer has a role in channel gating. Conductance and open probability
(Po) for Y4839A was reduced by 15 % and 76 % respectively compared to WT
RyR2. No single-channel experiments were performed for Y4813A due to
inherent protein instability when purified. Four unique gating modes including
subconductance states for D4829A were observed. Further experiments are
required to assess the role of the selectivity filter in gating.
Study supported by the British Heart Foundation.
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Looking for the Calcium-Binding Site in the Ryanodine Receptor’s
Vestibule
Janos Almassy, Sandor Sarkozi, Istvan Jona.
Department of Physiology, University of Debrecen, Debrecen, Hungary.
Ca2þ regulates ryanodine receptor’s (RyR) activity through a high-affinity
(activating) and a low-affinity (inhibiting) Ca2þ-binding site. Their altered
sensitivity plays an important role in the pathology of malignant hyperthermia
and heart failure. Although, the function of Ca2þ-binding sites has been exten-
sively studied, their location within the channel protein remains elusive. We
used Eu3þ as a tool to learn more about the Ca2þ-regulation of RyR, because
it has high affinity to Ca2þ-binding proteins and due to its high valency it is
more susceptible to be moved across an electric field than Ca2þ.
Eu3þwas tested on single RyR1 channels reconstituted into planar lipid bilayers.
When the activating binding site was saturated by 50 mM Ca2þ, Eu3þ potently
inhibited RyR’s open probability (kd=16755 nM nHill=250.1), but in nomi-
nally 0 [Ca2þ], low [Eu3þ] activated the channel. These results suggest that
Eu3þ acts as an agonist of both Ca2þ-binding sites. More interestingly, the action
of Eu3þwas voltage-dependent: at negativemembrane potentials, when the elec-
trical force tends to drive Eu3þ into the pore, >1 mM Eu3þ caused long closed
states by occluding the pore, but unexpectedly, %1 mM Eu3þ induced signifi-
cantly weaker inhibition compared to positive potentials (which drives positively
charged ions out from the outer vestibule). These findings led to the hypothesis
that negative potentials prevent Eu3þ-inhibition by increasing relative [Eu3þ]
in the vicinity of the activating site located within the vestibule. This idea was
further testedwith thepeptide-toxinmaurocalcine.We found thatRyRopenprob-
ability was insensitive to lowering [Ca2þ] to 100 nMas long as the toxin occluded
the vestibule. These results suggest, that maurocalcine mechanically prevented
Ca2þ from dissociating from its binding site, therefore the high-affinity binding
site (but not the low-affinity) might be located in the RyRs vestibule.
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Ligand-Dependent Conformational Changes in the Cardiac Ryanodine
Receptor
Yingjie Liu1, Xixi Tian1, Ruiwu Wang1, Terence Wagenknecht2,3,
Zheng Liu2, Suirong Wayne Chen1.
1Libin Cardiovascular Institute of Alberta, Calgary, AB, Canada,
2Wadsworth Center, Albany, NY, USA, 3State University of New York
at Albany, Albany, NY, USA.Global conformational changes in the three-dimensional (3D) structure of the
calcium release channel/ryanodine receptor (RyR) occur upon ligand activa-
tion. Of several ligands that activate RyR, Ca2þ is the primary activator.
Although RyR Ca2þ activation is well characterized functionally, little is
known about the conformational changes in RyR induced by Ca2þ. Here we
generated three fluorescence resonance energy transfer (FRET)-based
conformational probes. Each of these probes was constructed by inserting a
CFP into one domain and a YFP into a neighboring domain in the
cardiac RyR (RyR2) to yield a CFP- and YFP-dual labeled RyR2 (CFP/
YFP FRET pair). These CFP/YFP FRET pairs were located in the
‘‘clamp’’ region (RyR2S2367-CFP/Y2801-YFP), the calmodulin binding region
(RyR2R3595-CFP/K4269-YFP), and the ‘‘bridge’’ region (RyR2S437-YFP/S2367-CFP),
respectively. We monitored the conformational changes in these regions by
recording the FRET signals, and the extent of Ca2þ release by measuring store
Ca2þ depletion in HEK293 cells expressing each of the CFP/YFP FRET pairs
upon activation by Ca2þ, caffeine, and ATP. Surprisingly, we found that
different ligands induced different conformational changes in different regions
of RyR2. For instance, we detected conformational changes in the clamp region
for caffeine and ATP, but not for Ca2þ, although they all induced Ca2þ release.
Considering Ca2þ as the primary activator of RyR2, we determined the impact
of cytosolic Ca2þ sensing mutation E3987A on conformational changes. Inter-
estingly, this single mutation abolishes caffeine-induced conformational
changes, but not caffeine-induced Ca2þ release. These observations demon-
strate that conformational changes in RyR2 are ligand-dependent, and
that E3987, which is critical for cytosolic Ca2þ sensing, is essential for
ligand-induced conformational changes (Supported by CFI, CIHR, HSFC,
NIH, and LCIA).
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Structure-Function Relationship of Calcins, a Family of High-Affinity
Peptide Ligands of Ryanodine Receptors
Liang Xiao1, Georgina B. Gurrola2, Jing Zhang3, Mario San Martin3,
Fernando Z. Zamudio2, Lourival D. Possani2, He´ctor H. Valdivia3.
1Department of Marine Biotechnology, Faculty of Naval Medicine, Second
Military Medical University, Shanghai, China, 2Instituto de Biotecnologı´a
UNAM, Cuernavaca, Mexico, 3Center for Arrhythmia Research, University
of Michigan, Ann arbor, MI, USA.
Calcins is a novel family of scorpion peptides that bind with high affinity and
specificity to ryanodine receptors (RyRs) and increase their open probability
by inducing the appearance of a long-lasting subconductance state. Here we
report two newly-identified calcins (Vejocalcin and Urocalcin) and provide a
comprehensive analysis of the structure-function relationship of the eight
calcins known to date, based on primary sequence examination, 3D structure
modeling, and their effect on RyR1. [3H]Ryanodine binding assays, used as
index of the open probability (Po) of RyRs, revealed that all eight
calcins (Opicalcin1, Opicalcin2, Imperacalcin, Maurocalcin, Hadrucalcin,
Hemicalcin, Vejocalcin, and Urocalcin) activate RyR1 dose-dependently,
with EC50s (in nM) 0.35, 5, 8, 12, 37, 71, 91, and 523, respectively. At 1
mM, calcins significantly augmented the bell-shaped [Ca2þ]-activity curve
of RyR1 with potency Opicalcin1>Opicalcin2>Vejocalcin>Urocalcin.
In single channel recordings, the heretofore uncharacterized calcins
Opicalcin1, Opicalcin2 and Vejocalcin increased the Po of RyR1 signifi-
cantly and the fractional conductance was ~0.45, 0.30, and 0.65, respectively,
of the full conductance state. Opicalcin1, Maurocalcin, Hadrucalcin and
Vejocalcin induced Ca2þ release from rabbit skeletal SR with ED50s (in
nM) 2.850.02, 8.350.25, 1650.4, 3650.5, respectively. A clear Ca2þ
release-[3H]ryanodine binding activity correlation (r2=0.99) was obtained.
Primary sequence alignment and evolutionary analysis (ClustalW and
MEGA5.2) showed high homology among all calcins. An inhibitor
cysteine-knot (ICK) motif with babb domains stabilized by three disulfide
bridges characterizes this peptide family, although Vejocalcin lacks the b2
sheet. Positively-charged residue mutations in the high variable N-terminal
region (G1-N14) and negatively-charged residue variations in the conserved
C-terminal region (D15-R33) greatly decrease the effect of calcins on RyR1.
In conclusion, natural variation in calcin peptides offers a diversified set of
RyR ligands with capacity to modulate RyRs with high dynamic range
and potency.
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Mapping the Interacting Sites Mediating Tetramerisation of Ryanodine
Receptor Amino-Terminus
Monika Seidel, Paulina J. Stanczyk, F Anthony Lai, Spyros Zissimopoulos.
Cardiff University School of Medicine, Cardiff, United Kingdom.
The cardiac ryanodine receptor (RyR2) is an intracellular calcium release chan-
nel composed of four ~560kDa subunits. It mediates sarcoplasmic reticulum
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coupling. Recently, we presented evidence that the RyR2 N-terminus self-
associates into a tetrameric form, which stabilises the closed conformation of
the channel. In order to identify the interacting domains mediating RyR2
N-terminus tetramerisation, we used truncated constructs in yeast two-hybrid
and chemical cross-linking assays. RyR2 residues 1-418 remained in mono-
meric form, whereas residues 1-530 retained self-association ability although
it was much weaker compared to longer fragments. Tetramerisation was not
abolished by removal of the N-terminal 160 amino acids but further truncations
were detrimental. A targeted approach for putative inter-subunit contact sites
was also employed testing the effect of small internal deletions within RyR2
residues 1-906. We found that two small deletions (167-178 or 335-358 amino
acids) severely compromised tetramerisation ability. These findings suggest
that residues 167-178 and 335-358 are the primary interacting sites, whereas
additional downstream determinants further strengthen the RyR2 N-terminus
self-association.
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FRET-Based Trilateration of a Domain Peptide Bound within Functional
Ryanodine Receptors in Cardiomyocytes
Bengt Svensson1, Tetsuro Oda2, Florentin R. Nitu1, Iustin Cornea1,
Donald M. Bers2, David D. Thomas1, Razvan L. Cornea1.
1Biochemistry, Molecylar Biology and Biophysics, Univ. of Minnesota,
Minneapolis, MN, USA, 2Pharmacology, Univ. of California, Davis,
CA, USA.
We have used trilateration, the method of using distances to determine a
location in space, simulated annealing calculations, and confocal FRET mea-
surements in permeabilized rat myocytes to determine the topology of a
modulatory interface within the ryanodine receptor (RyR) Ca2þ channel. A
small peptide (~4kDa, termed DPc10), corresponding to a RyR central
stretch, hypothetically destabilizes a key interaction between RyR N-terminal
and central domains to promote the open channel. We used DPc10 labeled
with a small fluorophore, HiLyte Fluor 647, as FRET acceptor. Five
single-cysteine variants of the 12 kDa FK506-binding protein (FKBP) were
labeled with FRET donor, Alexa Fluor 488 C5 maleimide, and targeted to
RyR. Effective average positions of the donors were calculated from simu-
lated annealing, constrained by the RyR cryo-EM map and by the FKBP
atomic structure. FRET from the FKBP donors to the DPc10 acceptor was
measured via confocal microscopy, and the calculated distances were used
to trilaterate the acceptor location within the RyR 3D map. The trilateration
method uses the distances determined by FRET from each donor’s calculated
average position, where the ranges of the distances were based on measure-
ment precision for each donor labeling site. The DPc10-bound acceptor locus
is found at a region in space matching four distance ranges from FRET, and
was further constrained by FRET between donor-labeled calmodulin and
F-DPc10. This locus is near the RyR N-terminal domain structure docked
into the cryo-EM reconstructed map of RyR. Computational resources were
provided by the Minnesota Supercomputing Institute. This work was
supported by NIH grants R01HL092097 (to D.M.B. and R.L.C.), and
R01GM27906 (to D.D.T.).
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Evolution, Structure and Function of Ryanodine Receptor Domains
Zhiguang Yuchi, Filip Van Petegem.
Biochemistry and Molecular Biology, University of British Columbia,
Vancouver, BC, Canada.
Ryanodine receptors (RyRs) control the Ca2þ-release from sarcoplamic reticu-
lum (SR) and play an important role in excitation-contraction (EC) coupling.
Misregulation of the channel by mutations or hyperphosphorylation can cause
severe disease such as cardiac arrhythmias, heart failure and malignant hyper-
thermia. RyRs are the largest ion channels found in humans and consist of
dozens of functional domains that may act as separate modules. Interestingly,
a few domains are present multiple times in the channel due to the gene dupli-
cation. One of them, the so-called ‘‘RYR domain’’ is present four times in two
tandem repeats, one near the N-terminus and the other in the central region.
Previously we solved the crystal structure of the central repeat, which contains
several major phosphorylation sites in RyR. By analyzing the sequences and
structures of the different RYR domains from RyR and other proteins, we
were able to gain interesting insights about the evolution of the domain.
Some special structural features of the domain may be involved in the unique
function of the channel. Some other repeating domains in RyRs were also stud-
ied and compared to their analogues from different protein families. Potential
functions of these domains are proposed based on the evolutionary and struc-
tural relationships.566-Pos Board B321
Molecular Modeling and Structural Docking of a Ryanodine Receptor
SPRY2 Domain
Li Zhu1, Ruiwu Wang2, S.R. Wayne Chen2, Terence Wagenknecht1,
Zheng Liu1.
1Wadsworth Center, New York State Department of Health, Albany,
NY, USA, 2Departments of Physiology and Pharmacology, and of
Biochemistry and Molecular Biology, University of Calgary, Calgary,
AB, Canada.
Ryanodine receptors (RyRs) form a class of intracellular calcium release
channels in various excitable tissues and cells such as muscles and neurons.
SPRY domains are recognized as a protein interacting module and were so
named because they were identified in a Dictyostelium discoidueumsplA
kinase and in the mammalian RyR. There are 3 SPRY domains present in
all the RyR isoforms. A particular interest has been raised for the SPRY2
domain, as it has been identified as the binding partner for the II-III loop
from the a1S subunit of the dihydropyridine receptor, an interaction that is
thought to be crucial for skeletal excitation-contraction coupling. In the
present study, we have generated pseudo-atomic structures for RyR1 frag-
ment 1,071-1,208 and homologous RyR2 fragment 1,084-1,221, both of
which contain a SPRY2 domain. Both modeled SPRY2 fragments contain
multiple b-sheets. Our initial rigid-body docking model in the sub-
nanometer resolution cryo-EM map of RyR has placed the modeled fragment
into a cytoplasmic domain adjacent to the N-terminal and central mutation
region of RyR. Based on the modeled SPRY2 structure, we have designed
a RyR2-GFP construct, with GFP inserted after residue Arg-1084, the
N-terminus of the SPRY2 domain, to test our docking position by a 3D
cryo-EM study. Our preliminary 2D analysis result supported the docking
position.567-Pos Board B322
A Regulatory Component of the Human Ryanodine Receptor 2
N-Terminus
Lubomir Borko1, Vladena Bauerova-Hlinkova1,
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Laboratories, University of Vienna, Vienna, Austria, 4Cardiff University
School of Dentistry, Cardiff, United Kingdom, 5Department of Cardiology,
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Human cardiac ryanodine receptor (hRyR2) is a channel mediating Ca2þ
release from the sarcoplasmic reticulum during excitation-contraction
coupling. The N-terminal (1-655) and central (2100-2500) regions of
hRyR2 are thought to be involved in regulating channel gating. Mutations
linked to several heart diseases are clustered within these two, as well as in
the channel pore-containing C-terminal regions. High resolution structures
of key regions involved in the regulation of RyR2 activity could further the
understanding of the gating mechanism of hRyR2 and of its malfunction in
disease. Here we present the structure of the hRyR21-606 N-terminal region;
it shares a significant structural similarity with other solved N-terminal
RyR structures (pdb code: 2XOA, 4J4K) but lacks the chloride binding site
proposed for mouse RyR2 (4J4K). Structural data suggested high flexibility
of the region starting at around residue 544 predicted to consist of helices
forming an armadillo motif - a protein-protein interaction domain. Our
SAXS data showed high flexibility and partial unfolding of the C-terminal
part of hRyR21-606 beyond aa 544, suggestive of incompleteness of the
C-terminus. Biochemical data showed a weak tendency of hRyR21-606 to
form dimers. Prolonging the fragment to the end of the predicted RIH domain
increased the propensity to dimerize. A mutation introduced to a specific spot
of hRyR21-606 resulted in significant thermal destabilization and augmented
dimerization. Docking of the hRyR21-606 structure into cryo-EM maps of
RyR ruled out interactions of its C-terminus with neighbouring hRyR21-606
monomers. We interpret the formation of dimers as a surrogate for interaction
of the N-terminal region with an armadillo motif of another part of RyR2, and
propose the existence of a regulatory component at the secondary structure
level controlling interaction power at inter-monomer interfaces within the
RyR2 tetramer.
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